Company News

Galderma’s Differin Gel Gets OTC Approval

First new active ingredient for OTC acne category in more than 30 years

Author Image

By: Christine Esposito

Editor-in-Chief

Galderma Laboratories, L.P. received approval from the US Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acne. This approval makes Differin Gel the first and only OTC acne product containing a full prescription-strength retinoid.  It also marks the first new, FDA-approved active ingredient to be introduced to the OTC acne category in more than three decades.   “We believe bringing Differin Gel over-the-counter will be a...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters